Boston Scientific

YTD

ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.

CEO

Michael F. Mahoney

CEOMichael F. Mahoney

Employees

59,000

Employees59,000

Headquarters

Marlborough, Massachusetts

HeadquartersMarlborough, Massachusetts

Founded

1979

Founded1979

Employees

59,000

Employees59,000

BSX Key Statistics

Market cap

102.67B

Market cap102.67B

Price-Earnings ratio

36.19

Price-Earnings ratio36.19

Dividend yield

—

Dividend yield—

Average volume

12.04M

Average volume12.04M

High today

$70.13

High today$70.13

Low today

$68.85

Low today$68.85

Open price

$69.33

Open price$69.33

Volume

16.01M

Volume16.01M

52 Week high

$109.50

52 Week high$109.50

52 Week low

$67.56

52 Week low$67.56

Stock Snapshot

Boston Scientific(BSX) stock is priced at $69.40, giving the company a market capitalization of 102.67B. It carries a P/E multiple of 36.19.

As of 2026-03-28, Boston Scientific(BSX) stock has fluctuated between $68.85 and $70.13. The current price stands at $69.40, placing the stock +0.8% above today's low and -1.0% off the high.

Boston Scientific(BSX) shares are trading with a volume of 16.01M, against a daily average of 12.04M.

During the past year, Boston Scientific(BSX) stock moved between $67.56 at its lowest and $109.50 at its peak.

BSX News

Simply Wall St 19h

Boston Scientific Valuation Check As Electrophysiology Concerns And Lawsuit Weigh On Sentiment

Boston Scientific (BSX) stock has come under pressure after a class action lawsuit accused the company of misleading investors about its Electrophysiology growt...

TipRanks 1d

Boston Scientific price target lowered to $93 from $98 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Boston Scientific (BSX) to $93 from $98 but keeps a Buy rating on the shares. The firm is revising its base cas...

Simply Wall St 2d

Will Conference Focus on Cardiovascular Platforms and FARAPULSE, WATCHMAN Shape Boston Scientific's Narrative?

Earlier in March 2026, Boston Scientific presented at the Life Science Intelligence Summit, featuring senior leaders including Vice President Isaac Knoot and Ch...

Analyst ratings

97%

of 37 ratings

Buy

97.3%

Hold

2.7%

Sell

More BSX News

TipRanks 4d

Boston Scientific’s Agent DCB: Strong Early Adoption and Underappreciated Multiyear Growth Opportunity

TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific today and set a price target of $100.00. Claim 30% Off TipRanks Premium Unlock hedge...

Simply Wall St 6d

Boston Scientific’s EMEA Urology Push May Reframe Valuation Story

Boston Scientific (NYSE:BSX) is expanding its urology business in EMEA through the acquisitions of Axonics and Valencia Technologies. The deal broadens patient...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.